Fundació Lluita contra les Infeccions

Recent papers from Fundació Lluita contra les Infeccions

1. Mpox in people with advanced HIV infection: a global case seriesThe Lancet · 2023
2. MonkeypoxThe Lancet · 2022
3. Strengthening tuberculosis clinical trial implementation: operational challenges, lessons learned, and consensus recommendations from a Delphi studyBMC Public Health · 2026
4. First-line dolutegravir/lamivudine in HIV-1 infection: lymph node penetration and reservoir decline in a randomized open-label clinical trialNature Communications · 2026
5. Evaluation of dual path platform optical density in relation to RPR titers and serological response in syphilis: a cross-sectional and longitudinal studyInternational Journal of Infectious Diseases · 2026
6. Andes hantavirus: operationalising science in real timeThe Lancet · 2026
7. Virologic insights from the phase 3 REDPINE trial: remdesivir in renally impaired and immunocompromised patients with COVID-19Antimicrobial Agents and Chemotherapy · 2026
8. Blinded two-year longitudinal evaluation of SARS-CoV-2 antigenemia in long COVIDClinical Microbiology and Infection · 2026
9. Ensitrelvir for the treatment of hospitalized adults with COVID-19: an international phase 3 randomized placebo-controlled trialClinical Infectious Diseases · 2026
10. Multiparametric Characterization of Telomere Length in T Cells by Flow‐FISHCurrent Protocols · 2026
11. Clostridioides difficile infection: Position paper of the Catalan Society of GastroenterologyGastroenterología y Hepatología (English Edition) · 2026
12. Concordance and Acceptability of Self‐ Vs. Clinician‐Collected Anorectal Swabs for HPV Genotyping in Gay, Bisexual and Other Men Who Have Sex With Men in Metropolitan BarcelonaJournal of Medical Virology · 2026
13. The etiology of exudative cutaneous ulcers in a yaws-endemic community prior to receipt of antimicrobials is similar to that found in communities after mass treatment with azithromycinmSphere · 2026
14. Closing the PrEP access gap in Europe: a strategic framework for equity and innovation among difficult-to-reach populationsJournal of Antimicrobial Chemotherapy · 2026
15. The presence of a positive blood culture should be regarded a risk factor for DAIR failure in cases of haematogenous total knee arthroplasty infectionJournal of Orthopaedics and Traumatology · 2026
16. Effect of repeated mass drug administration on the transmission of yaws: a retrospective genomic epidemiology studyThe Lancet Microbe · 2026
17. Post-COVID-19 condition patients’ utilisation of healthcare resources after implementation of an integrated care unitCost Effectiveness and Resource Allocation · 2025
18. Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial)Journal of Infection · 2025
19. Patient and donor antibody profiles in early COVID-19 convalescent plasma therapy in the COnV-ert trialFrontiers in Immunology · 2025
20. Emergent Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance in Randomized Trials of Contemporary Antiretroviral RegimensClinical Infectious Diseases · 2025